ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,551,000 | -62.0% | 54,069 | -72.7% | 0.00% | -69.2% |
| Q2 2021 | $25,126,000 | +7537.1% | 197,809 | +7675.5% | 0.01% | – |
| Q1 2021 | $329,000 | +34.3% | 2,544 | +21.4% | 0.00% | – |
| Q4 2020 | $245,000 | +5.6% | 2,095 | -0.8% | 0.00% | – |
| Q3 2020 | $232,000 | -7.9% | 2,111 | -15.7% | 0.00% | – |
| Q2 2020 | $252,000 | +27.9% | 2,505 | +6.4% | 0.00% | – |
| Q1 2020 | $197,000 | -56.9% | 2,354 | -72.6% | 0.00% | – |
| Q4 2019 | $457,000 | +172.0% | 8,600 | +101.8% | 0.00% | – |
| Q3 2019 | $168,000 | +4.3% | 4,261 | +8.6% | 0.00% | – |
| Q2 2019 | $161,000 | +3925.0% | 3,922 | +4163.0% | 0.00% | – |
| Q1 2019 | $4,000 | -94.5% | 92 | -94.5% | 0.00% | – |
| Q4 2018 | $73,000 | -32.4% | 1,684 | -10.9% | 0.00% | – |
| Q3 2018 | $108,000 | +272.4% | 1,891 | +214.6% | 0.00% | – |
| Q2 2018 | $29,000 | +123.1% | 601 | +84.4% | 0.00% | – |
| Q1 2018 | $13,000 | -79.0% | 326 | -77.8% | 0.00% | – |
| Q4 2017 | $62,000 | +12.7% | 1,470 | 0.0% | 0.00% | – |
| Q3 2017 | $55,000 | -79.9% | 1,470 | -83.6% | 0.00% | – |
| Q2 2017 | $273,000 | +15.2% | 8,971 | 0.0% | 0.00% | – |
| Q1 2017 | $237,000 | -63.6% | 8,971 | -46.3% | 0.00% | – |
| Q4 2014 | $651,000 | +10750.0% | 16,700 | +9177.8% | 0.00% | – |
| Q2 2014 | $6,000 | – | 180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |